Correlation Between Inhibrx and 49327M3G7
Specify exactly 2 symbols:
By analyzing existing cross correlation between Inhibrx and KEY 47 26 JAN 26, you can compare the effects of market volatilities on Inhibrx and 49327M3G7 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of 49327M3G7. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and 49327M3G7.
Diversification Opportunities for Inhibrx and 49327M3G7
Good diversification
The 3 months correlation between Inhibrx and 49327M3G7 is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and KEY 47 26 JAN 26 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on KEY 47 26 and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with 49327M3G7. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of KEY 47 26 has no effect on the direction of Inhibrx i.e., Inhibrx and 49327M3G7 go up and down completely randomly.
Pair Corralation between Inhibrx and 49327M3G7
Given the investment horizon of 90 days Inhibrx is expected to generate 7.02 times more return on investment than 49327M3G7. However, Inhibrx is 7.02 times more volatile than KEY 47 26 JAN 26. It trades about 0.01 of its potential returns per unit of risk. KEY 47 26 JAN 26 is currently generating about 0.0 per unit of risk. If you would invest 2,418 in Inhibrx on October 11, 2024 and sell it today you would lose (920.00) from holding Inhibrx or give up 38.05% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 71.98% |
Values | Daily Returns |
Inhibrx vs. KEY 47 26 JAN 26
Performance |
Timeline |
Inhibrx |
KEY 47 26 |
Inhibrx and 49327M3G7 Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Inhibrx and 49327M3G7
The main advantage of trading using opposite Inhibrx and 49327M3G7 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, 49327M3G7 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 49327M3G7 will offset losses from the drop in 49327M3G7's long position.Inhibrx vs. Crinetics Pharmaceuticals | Inhibrx vs. Merus BV | Inhibrx vs. Lyell Immunopharma | Inhibrx vs. Kronos Bio |
49327M3G7 vs. Sonida Senior Living | 49327M3G7 vs. Valmont Industries | 49327M3G7 vs. MYR Group | 49327M3G7 vs. Inhibrx |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |